At present, the Baylor Sammons Renal Cell Cancer Center is a leading accruer
to two major phase III trials evaluating novel agents for the treatment of metastatic disease, both of which will likely impact the treatment of this cancer.
Pluard led numerous clinical trials at Siteman Cancer Center over the past eight years, and his active role in research resulted in him being recognized twice by NCI as one of the nation's top accruers
in cooperative group trials.
And 24 per cent were accidental accruers
who did not splash out so had money left over.